Literature DB >> 3088257

Effect of verapamil on prostaglandin E2 synthesis by hydronephrotic rabbit cortical interstitial cells in primary culture.

A Danon, T V Zenser, D L Thomasson, B B Davis.   

Abstract

The effect of the calcium channel blocker verapamil on prostaglandin (PG) E2 production by hydronephrotic cortical interstitial cells in primary culture was investigated. Verapamil displayed a dual action, maximally enhancing PGE2 production from 1.2 +/- 0.2 to 30.7 +/- 4.3 ng/ml at 30 microM, whereas at higher concentrations the effect tapered down to base line. Stimulation of PGE2 synthesis by verapamil required extracellular calcium, but was unaffected by the intracellular calcium inhibitor 8-(Diethylamino)octyl 3,4,5-trimethoxy-benzoate or the calmodulin inhibitor trifluoperazine. Other calcium channel blockers, nifedipine and diltiazem, failed to stimulate PGE2 synthesis, implying that this effect of verapamil was unrelated to its commonly recognized action to inhibit calcium channels. However, stimulation by verapamil was inhibited by quinacrine (mepacrine), suggesting a mechanism involving activation of a phospholipase. In addition, verapamil attenuated the bradykinin- or ionophore A23187-stimulated PGE2 production, but it did not alter arachidonic acid-induced PGE2 synthesis. These observations indicate that, in addition to phospholipase activation, verapamil may also act to inhibit phospholipase activity. Inhibition was concentration-dependent over the range 3 to 300 microM, and was reversible. It is concluded that verapamil, at different concentrations, exerts a dual action on cellular phospholipase activity, thereby stimulating, and in turn inhibiting, PGE2 synthesis by hydronephrotic interstitial cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088257

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  1 in total

1.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.